Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Forian (FORA) Research & Development (2020 - 2025)

Forian filings provide 6 years of Research & Development readings, the most recent being $958582.0 for Q4 2025.

  • On a quarterly basis, Research & Development rose 110.36% to $958582.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 101.88% increase, with the full-year FY2025 number at $2.9 million, up 101.88% from a year prior.
  • Research & Development hit $958582.0 in Q4 2025 for Forian, up from $676172.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.9 million in Q4 2021 to a low of $264781.0 in Q3 2023.
  • Median Research & Development over the past 5 years was $675951.5 (2025), compared with a mean of $937728.0.
  • Biggest five-year swings in Research & Development: surged 357.3% in 2021 and later tumbled 78.57% in 2023.
  • Forian's Research & Development stood at $2.9 million in 2021, then crashed by 76.19% to $694263.0 in 2022, then tumbled by 55.79% to $306923.0 in 2023, then surged by 48.47% to $455693.0 in 2024, then surged by 110.36% to $958582.0 in 2025.
  • The last three reported values for Research & Development were $958582.0 (Q4 2025), $676172.0 (Q3 2025), and $675731.0 (Q2 2025) per Business Quant data.